These results indicate that the promoter hypermethylation of ZNF671 mediates its downregulation in BLCA, BRCA, CESC, COAD, HNSC, KIRP, LUAD, LUSC, PAAD, PRAD, READ, SARC, STAD, THCA, and UCEC cancers. Here, ZNF671 is linked to cancer.